Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Neurizon Therapeutics Limited
Neurizon Therapeutics Limited
NUZ · ASX

Neurizon Therapeutics Limited

AU$0.12

Price Arrow-0.005 (-4.00%)
28/10/2025 01:09:21 PM
All-CompaniesGROWTH AUSHALO Consensus ValueHALO Ords
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Neurizon Therapeutics Limited Overview

NUZ Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About NUZ

icon

Telephone

61.3.9692.7222

icon

Address

Level 11, Suite 2, 385 Bourke Street, Melbourne, Victoria (VIC) 3000

Description

Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. It operates under the Corporate and Research, and Pharmaceutical-Epichem segments. The Corporate and Research segment includes corporate overhead expenses. The Pharmaceutical-Epichem segment provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The company was founded on December 2003 and is headquartered in Claremont, Australia.

NUZ Price Chart

Key Stats

Market Cap

AU$66.82M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.1 - 0.22

Trade Value (12mth)

AU$18,327.00

1 week

-3.85%

1 month

-3.85%

YTD

-24.24%

1 year

-39.02%

All time high

4.74

Key Fundamentals

EPS 3 yr Growth

529.60%

EBITDA Margin

0.00%

Operating Cashflow

-$14m

Free Cash Flow Return

-219.10%

ROIC

-254.30%

Interest Coverage

0.00

Quick Ratio

2.80

Other Data

Shares Outstanding (Fully Diluted)

492m

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

NUZ Announcements

Latest Announcements

DateAnnouncements
23 October 25
21 October 25
20 October 25
10 October 25
08 October 25

NUZ Fundamentals

Per Share Records

Historical data

Forecast data

AUD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.02-0.02-0.03locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.02-0.02-0.03locklocklock
Growth
%locklocklocklock-259.3-25.8-39.3locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

Short Selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

0

7 Day Change

0.00%

1 Month Change

0.00%

3 Months Change

0.00%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

NUZ Shortsell

Want to learn more?Frequently asked questions.
What is the current share price of Neurizon Therapeutics Limited (NUZ:ASX)?
Halo FAQ
The current share price of Neurizon Therapeutics Limited (NUZ:ASX) is AUD$0.12.
What is the 52-week high share price for Neurizon Therapeutics Limited (NUZ:ASX)?
Halo FAQ
The 52-week high share price for Neurizon Therapeutics Limited (NUZ:ASX) is AUD$0.22.
What is the 52-week low share price for Neurizon Therapeutics Limited (NUZ:ASX)?
Halo FAQ
The 52-week low share price for Neurizon Therapeutics Limited (NUZ:ASX) is AUD$0.10.
What is the dividend yield for Neurizon Therapeutics Limited (NUZ:ASX)?
Halo FAQ
Neurizon Therapeutics Limited (NUZ:ASX) does not pay a dividend.
What was Neurizon Therapeutics Limited (NUZ:ASX) last dividend payment?
Halo FAQ
Neurizon Therapeutics Limited (NUZ:ASX) does not pay a dividend.
What is the franking level for Neurizon Therapeutics Limited (NUZ:ASX)?
Halo FAQ
Neurizon Therapeutics Limited (NUZ:ASX) has a franking level of 0.00%.
In which sector is Neurizon Therapeutics Limited (NUZ:ASX) classified?
Halo FAQ
Neurizon Therapeutics Limited (NUZ:ASX) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.